Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2023

Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study.

Yukari Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.